Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA

Current Biology

Volumn 6, Issue 6, 1996, Pages 750-752

  Marsters, Scot A ^a   Pitti, Robert M ^a   Donahue, Christopher J ^a   Ruppert, Siegfried ^a   Bauer, Kenneth D ^a   Ashkenazi, Avi ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COWPOX VIRUS;

APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; FADD PROTEIN, HUMAN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; INTERLEUKIN 2; INTERLEUKIN-1BETA-CONVERTING ENZYME INHIBITOR; MEMBRANE PROTEIN; SERINE PROTEINASE INHIBITOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; INTERLEUKIN-2; MEMBRANE GLYCOPROTEINS; SERPINS; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0030155964     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(09)00456-4     Document Type: Article

References (23)

1. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 Ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996, 271:12687-12690.
2. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al.: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
3. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 1994, 6:279-289.
4. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456.
5. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995, 377:348-351.
6. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
7. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Cmonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995, 270:387-391.
8. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996, 84:299-308.
9. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, et al.: FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996, 271:4961-4965.
10. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ: Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β-converting enzyme. Cell 1992, 69:597-604.
11. Nicholson D, Ambereen A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376:37-43.
12. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Biedler DR, et al.: Yama/CPP32ß, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995, 81:801-809.
13. Lenardo MJ: Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991, 353:858-861.
14. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992, 140:197-205.
15. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Internatl Immunol 1993, 5:625-630.
16. Yin DX, Schimke RT: BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 1995, 55:4922-4928.
17. Martin SJ, Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 1995, 82:349-352.
18. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995, 375:78-81.
19. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, et al.: Requirement of an ICE-CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995, 375:81-84.
20. Tewari M, Dixit VM: Fas- and TNF-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995, 270:3255-3260.
21. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530.
22. Fadok VA, Voelker DR, Campbell PA, Choen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207-2214.
23. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.